Session Details
[2-P]Poster
Tue. Mar 17, 2026 1:00 PM - 2:00 PM JST
Tue. Mar 17, 2026 4:00 AM - 5:00 AM UTC
Tue. Mar 17, 2026 4:00 AM - 5:00 AM UTC
ポスター会場5(B205)
[2-P-045]Descending input from the somatosensory cortex to the spinal dorsal horn contributes to neuropathic allodynia
*Eriko I1, Sho Shinotsuka1,2, Daichi Sueto1, Kazuki Fujimori1, Ken Yamaura2, Makoto Tsuda1 (1. Grad. Sch. Phar. Sci., Kyushu Univ., 2. Grad. Sch. Med. Sci., Kyushu Univ.)
[2-P-046]The effect of chronic pain on electrophysiological properties of BNST-projecting vSUB neurons
*Madoka Sakai1, Minami Masabumi1 (1. Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Hokkaido University)
[2-P-047]Antagonist peptide administration suppresses mechanical allodynia in a neuropathic pain mouse model
*Ayana Ota1, Namika Arai1, Takasi Kurihara2, Kotaro Sakamoto3, Yukio Ago4, Ichiro Takasaki1,5 (1. Toyama University Graduate School of Pharma-Medical Sciences , 2. Kagoshima University Graduate School of Medical and Dental Sciences, 3. esearch and Development Department, Ichimaru Pharcos Company Limited, Gifu, Japan, 4. Hiroshima University Graduate School of Biomedical and Health Sciences, 5. University of Toyama School of Engineering)
[2-P-048]Intrathecal Administration of Anti-CADM1 Antibody Provides Long-Term Suppression of Mechanical Allodynia in a Neuropathic Pain Mouse Model
*Hayate Kinoshita1, Fuka Takeuchi2, Ryohei Miyamae1, Yuto Mochizuki3, Mitsuru Hagiyama2, Azusa Yoneshige2, Takao Inoue2, Tetsuo Narumi4, Akihiko Ito2, Ichiro Takasaki1,3 (1. University of Toyama Graduate School of Pharma-Medical Sciences, 2. Kindai University Graduate School of Medical Sciences, 3. University of Toyama School of engineering, 4. Shizuoka University Graduate School of Integrated Science and Technology)
[2-P-049]Topical gabapentinoids relieve neuropathic pain via peripheral suppression of spinal activity
*Misa Oyama1, Nozomi Yamada1, Yuka Okabe1, Hikari Nagasawa1, Mayuko Yoshikawa1, Takashi Iwai1, Shun Watanabe1, Mitsuo Tanabe1 (1. Lab. of Pharmacol., Sch. of Pharm., Kitasato Univ.)
[2-P-050]Acute spike responses of lateral habenular neurons to stress
*Hana Samejima1, Yuji Ikegaya1,2 (1. The University of Tokyo, 2. Institute of AI and Beyond)
[2-P-051]Evaluation of efficacy of anti-depressant drugs in the social defeat stress model
*Chika Nagao1, Masana Kamioka1, Yoshiyuki Hayashida1, Takashi Tashiro1, Kousuke Morizumi1, Katsuhide Nishi1, Naoyuki Hironaka1 (1. Research Unit Ⅰ Drug Discovery Innovation Center Mediford corporation)
[2-P-052]Role of α7 nicotinic ACh receptor signaling in social behaviors in mice exposed to social defeat stress as juveniles.
*Masaki Kano1, Kazuna Morikawa1, Mayu Ozaki1, Niina Bannno1, Mizuki Uchida, Norio Ozaki2, Akira Yoshimi1, Yukihiro Noda1 (1. Division of Clinical Sciences and Neuropsychopharmacology, Faculty and Graduate School Pharmacy, Meijo University, 2. Pathophysiology of Mental Disorders, Nagoya University Graduate School of Medicine)
[2-P-053]Early-life vicarious social defeat stress increases stress vulnerability in adult mice
*Hiroki Furuie1, Yuko Nakatake1, Mitsuhiko Yamada2 (1. National Center of Neurology and Psychiatry, 2. Tokyo Kasei Gakuin Univ.)
[2-P-054]Reduction of the hippocampal anandamide in mice exposed to chronic restraint stress
*Ryo Fukumori1, Asuka Uchida1, Yuki Sakata1, Taku Yamaguchi1 (1. Pharmacother. and Neuropsychopharmacol., Fac. Pharmaceut. Sci., Nagasaki Intl. Univ.)
[2-P-055]Chronic stress induces progressive neural circuit remodeling and persistent behavioral alterations
*Marina Yamamoto1, Yuki Okuda1, Dongrui Li1, Hirokazu Sonobe1, Yuzuki Maruyama1, Masahiro Yamaguchi2, Kei N. Ito2, Akinori Y. Sato2, Fumitaka Osakada2, Ryota Shinohara1,3, Tomoyuki Furuyashiki1,3 (1. Div Pharmacol, Kobe Univ Grad Sch Med, 2. Lab Cell Pharmacol, Grad Sch Pharm Sci, Nagoya Univ, 3. Dept Pharmacol, Grad Sch Med Dent Sci, Inst Sci Tokyo)
[2-P-056]Chronic social defeat stress affects neurogenesis in the dentate gyrus of the hippocampus
*Takehisa Tsutsui1, Kenta Nakamura1, Kotomi Watanabe1, Hengbo Zhang1, Kanzo Suzuki1, Eri Segi1 (1. Department of Biological Science and Technology, Faculty of Advanced Engineering, Tokyo University of Science)
[2-P-057]Sex differences in stress adaptation and hippocampal myelin alterations in mice
*Kazuhiro Kurokawa1, Kohei Takahashi1, Hiroshi Takeda1, Minoru Tsuji1 (1. Department of Pharmacology, School of Pharmacy, International University of Health and Welfare)
[2-P-058]Involvement of complement component C3 in microglia-synapse interactions in the hippocampus of tumor-resection mice
*Takumu Yamasaki1, Yuko Hirano1, Yusuke Onaka1, Taro Yamaguchi1, Masanori Yoneyama1 (1. Setsunan Univ.)
[2-P-059]Intranasal Oxytocin in the Subacute Phase Improves Outcomes in a Mouse Model of Cerebral Infarction
*Youichirou Higashi1, Yusuke Morishita2, Daichi Tani3, Mio Togo1, Takahiro Shimizu1, Motoaki Saito1 (1. Department of Pharmacology, Kochi Medical School, Kochi University, 2. Department of Pediatrics, Kochi Medical School, Kochi University, 3. Center for innovative and Translational Medicine, Kochi Medical School, Kochi University)
[2-P-060]Nicotine Enhances Remyelination by Modulating Oligodendrocyte Progenitor Cells Differentiation and Glial Responses in a Cuprizone-Induced Demyelination Model
*Takuro Iwao1, Fuyuko Takata1, Yasuyoshi Tanaka1, Hisataka Aridome1, Shinya Dohgu1 (1. Dept. Pharmaceut. Care & Health Sci., Fac. Pharmaceut. Sci., Fukuoka Univ.)
[2-P-061]Tandospirone, a serotonin 1A (5-HT1A) receptor partial agonist exerts neuroprotective effects against dopaminergic neurodegeneration in parkinsonian model mice
*Masato Asanuma1, Soutaro Kobayashi2, Mitsuki Tsuda2, Suzuka Ono2, Akane Miyako2, Kana Tomimoto1, Kaori Masai1, Ikuko Miyazaki1 (1. Dept. of Med. Neurobiol., Okayama Univ. Grad. Sch. of Med., Dent. and Pharmaceut. Sci., 2. Dept. of Med. Neurobiol., Okayama Univ. Med. Sch.)
[2-P-062]Expression of Connexin43 in cultured astrocytes
*Koh-ichi Tanaka1,2, Kotaroh Azuma1, Kazuo Tomita1,2, Kento I1,2, Tomoaki Sato2 (1. Hyogo Medical Univ., 2. Kagoshima Univ.)